Julian Adams insider trades

Open-market stock purchases and sales by Julian Adams, Director at Elicio Therapeutics, Inc, from SEC Form 4 filings since Jan 5, 2010.

Recent trades

DateStockTradeValue
Aug 31, 2026ELTX Elicio Therapeutics, IncBought (not open market)—

Companies traded

  • ELTX Elicio Therapeutics, Inc: other filings, last Aug 31, 2026
  • GMDA Gamida Cell Ltd: other filings, last Jan 31, 2024
  • PIRS Pieris Pharmaceuticals, Inc: other filings, last Jan 25, 2018
  • INFI Infinity Pharmaceuticals, Inc: other filings, last Oct 31, 2016

Get free alerts when Julian Adams files a new trade →